McDermott Will & Schulte advises Cadence as health regulatory counsel in $100 million Series C led by Spark Capital | McDermott

McDermott Will & Schulte, a global law firm

PRESS RELEASE

McDermott Will & Schulte advises Cadence as health regulatory counsel in $100 million Series C led by Spark Capital

June 24, 2026

Read time: 2 min

Global law firm McDermott Will & Schulte advised Cadence, a care management and remote patient monitoring company utilizing AI to manage chronic care for older adults, as health regulatory counsel in connection with its $100 million Series C financing led by Spark Capital. The investment values Cadence at $1.23 billion. Thrive Capital, General Catalyst, Coatue, B Capital, Corewell Health Ventures, Memorial Hermann, and Duke Health also participated in the fundraising.

Cadence announced that the new investment will help scale its clinical AI agents and that it will focus on expansion across new health systems, advancement of Cadence’s AI agents and growth in value-based care models. Cadence currently treats more than 100,000 patients at 21 health systems.

The McDermott team was led by Caroline Reignley with invaluable support from Patrick Zanayed and Grayson Dimick. Jed Spielman, Lisa Mazur and Charlie Buck are the relationship partners for Cadence.

Read the press release here.

In this article

Patrick Zanayed

Partner

Chicago

Grayson I. Dimick

Associate

Washington, DC

Lisa Mazur

Partner

Chicago

Charles R. Buck

Partner

Boston

You may also like